Chemo-Gut Probiotic Study
The Chemo-Gut Probiotic Trial uses a double-blinded placebo-controlled design, in which cancer survivors who have undergone chemotherapy will be randomly assigned to take either a novel oral probiotic treatment or a placebo pill, once daily, for 12 weeks.
​
The purpose of this study is to determine whether the probiotic treatment impacts gastrointestinal symptoms, mental health, and the gut microbiome.
Want to learn more about Chemo-Gut?
-
Be experiencing GI issues​
-
Have been diagnosed with hematological cancers (leukemia, Hodgkin’s, and non-Hodgkin lymphoma), breast, osteosarcoma, Ewing’s sarcoma, thyroid, head and neck (e.g. laryngeal, esophageal), stomach, gynecological (cervical, endometrial), prostate, or testicular cancer.​
-
Have received chemotherapy.​
-
Be within 5 years from your final cancer treatments.​
-
Be 18 years or older​
-
Be willing to provide stool samples.​
-
Be able to speak, read, and write English sufficiently to participate in all activities.